Management of Ulcerated Scrotal Infantile Hemangioma in an Infant
Overview
This case report presents the effective management of an ulcerated scrotal infantile hemangioma in a 5-month-old male using systemic propranolol and topical moist dressings. The combined treatment resulted in rapid healing and favorable cosmetic outcomes.
Background
Ulcerated infantile hemangiomas (UIHs) are a significant clinical challenge, particularly when located in high-risk areas such as the scrotum. These lesions can lead to complications including infection and prolonged healing times. Effective management strategies are essential to improve patient outcomes and minimize complications.
Data Highlights
The patient achieved complete epithelialization of the ulcer within 12 days of treatment, with infection controlled in 3 days. Follow-up at three months showed no significant hypertrophic scarring.
Key Findings
Systemic propranolol at a maintenance dose of 2 mg/kg/d was effective in managing the hemangioma.
Topical moist wound healing strategies, including alginate dressings and recombinant human epidermal growth factor gel, facilitated rapid healing.
The combined treatment approach led to complete epithelialization of the ulcer within 12 days.
Localized infection was controlled within 3 days of initiating treatment.
Three-month follow-up confirmed favorable cosmetic results with no significant hypertrophic scarring.
Clinical Implications
This case highlights the importance of a multimodal approach in treating ulcerated infantile hemangiomas, particularly in sensitive anatomical areas. Clinicians should consider combining systemic beta-blockers with tailored local wound care to optimize healing and cosmetic outcomes.
Conclusion
The successful management of this case underscores the potential benefits of integrating systemic propranolol with customized moist wound healing strategies for ulcerated infantile hemangiomas. Further studies may help to refine treatment protocols.
